Recurrent Myxoid Liposarcoma

1 clinical trials · Condition

Record	Firm	Date
Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma (NCT03450122)	M.D. Anderson Cancer Center	2018-09-13

Every clearance here is in the API, with alerts when new ones post.